EAGLE ASSET MANAGEMENT INC - SYNAGEVA BIOPHARMA CORP ownership

Quarter-by-quarter ownership
EAGLE ASSET MANAGEMENT INC ownership history of SYNAGEVA BIOPHARMA CORP
ValueSharesWeighting
Q1 2015$36,263,000
+195.3%
371,816
+180.9%
0.21%
+193.0%
Q4 2014$12,280,000
-33.6%
132,345
-50.8%
0.07%
+34.0%
Q3 2014$18,486,000268,7900.05%
Other shareholders
SYNAGEVA BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Baker Brothers Advisors 10,660,432$989,182,00010.10%
BB BIOTECH AG 1,130,476$104,897,0003.40%
BLUE JAY CAPITAL MANAGEMENT, LLC 80,000$7,423,0003.31%
Opus Point Partners Management, LLC 20,002$1,856,0001.84%
COLUMBIA WANGER ASSET MANAGEMENT LLC 3,847,094$356,972,0001.77%
SECTORAL ASSET MANAGEMENT INC 363,884$33,765,0001.52%
Cormorant Asset Management, LP 100,000$9,279,0001.43%
Tekla Capital Management LLC 223,020$20,694,0000.97%
Lamond Capital Partners LLC 15,390$1,428,0000.94%
Squarepoint Ops LLC 6,700$622,0000.60%
View complete list of SYNAGEVA BIOPHARMA CORP shareholders